IN8bio, Inc. (INAB) vs Sintx Technologies, Inc. (SINT)
A side-by-side comparison of IN8bio, Inc. and Sintx Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INAB
IN8bio, Inc.
$1.39HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SINT
Sintx Technologies, Inc.
$2.18HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — INAB vs SINT
growth of $100 · dividends reinvested · last 5yINAB -99.4% (-64.4%/yr)SINT -100.0% (-82.1%/yr)INAB compounded faster over this window
Log scale — wide-divergence pair
INAB SINT
INAB vs SINT: by the numbers
- •SINT is the larger company ($14M vs $13M market cap).
- •Both run net losses; INAB's is the smaller (0.00% vs -1303.40% net margin).
Metrics side by side
Valuation
| Metric | INAB | SINT |
|---|---|---|
| P/S ratio | N/A | 10.04 |
| P/B ratio | 0.73 | 2.87 |
Profitability
| Metric | INAB | SINT |
|---|---|---|
| Gross margin | 0.00% | -19.74% |
| Operating margin | 0.00% | -1053.14% |
| Net margin | 0.00% | -1303.40% |
| ROE | -101.66% | -372.67% |
| ROIC | -91.74% | -157.90% |
Growth (annualized)
| Metric | INAB | SINT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 29.18% |
| Total return CAGR (5Y) | -62.88% | N/A |
Go deeper
Dig into the metrics
IN8bio ROESintx Technologies ROEIN8bio operating marginSintx Technologies operating marginIN8bio revenue growthSintx Technologies revenue growthIN8bio free cash flowSintx Technologies free cash flow
IN8bio & Sintx Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.